With cyberattacks becoming increasingly common, the FDA has issued long-awaited draft guidance to help device makers deal with the threat.
Subscribe today for full access
to all of these articles.
The FDA designated 213 submissions as breakthrough devices in 2021, the most awarded in a single year, by far.
On Jan. 11, the FDA warned consumers not to use COVID-19 tests from LuSys Laboratories, as they have not been approved for use in the US.